SARS-CoV-2 Nucleocapsid Protein Antibody (FITC)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein Antibody is a chimaeric recombinant antibody conjugated to FITC for the detection of SARS-CoV-2/COVID-19 NP. This antibody is expressed in HEK293 cells and contains Mouse scFv and C-terminal Human IgG1 Fc tag.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx243134-100UL |
| Pricing | 100 µl USD $464.0 |
| Clonality | Monoclonal |
| Conjugation | FITC |
| Host | Human, Mouse |
| Tested Applications | ELISA |
| UniProt Primary AC | P0DTC9 |
| Dry Ice | No |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only. |